Gout is a painful form of inflammatory arthritis caused by the accumulation of uric acid crystals in the joints. Managing gout involves a two-pronged approach: treating acute attacks and preventing future flares and complications by lowering uric acid levels. Understanding the different types of medications available is crucial for effective long-term management.
Table of contents
Treating Acute Gout Attacks
The primary goal during an acute gout flare is to reduce inflammation and alleviate pain. Medications for acute attacks differ from those used for long-term prevention and are generally not started during a flare if a patient has never used uric acid-lowering medication before.
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs): These are often the first-line treatment for acute gout. They work by reducing inflammation and pain. Examples include naproxen‚ indomethacin‚ and ibuprofen;
- Colchicine: This medication can be highly effective in reducing gout pain and inflammation‚ especially if taken within the first 24 hours of a flare. It works by inhibiting inflammatory processes triggered by uric acid crystals.
- Corticosteroids: For severe attacks or when NSAIDs or colchicine are contraindicated‚ corticosteroids (e.g.‚ prednisone) can be prescribed. They can be taken orally or injected directly into the affected joint to quickly reduce inflammation.
Preventing Gout Complications: Uric Acid-Lowering Medications (ULTs)
Uric acid-lowering therapies (ULTs) are the cornerstone of long-term gout management. These medications are designed to reduce the amount of uric acid in the body‚ thereby preventing the formation of new crystals and dissolving existing ones. The American College of Rheumatology (ACR) guidelines recommend ULTs for individuals with:
- Tophi (nodules formed by uric acid crystals)
- Radiographic evidence of damage due to gout
- Kidney stones (an increased risk in people with gout)
- Two or more gout flares per year
The ACR guidelines aim to lower uric acid levels to less than 6 mg/dL (or 360 µmol/L). For patients with tophi‚ the target serum uric acid (sUA) level is even lower‚ under 5 mg/dL (300 µmol/L).
Types of Urate-Lowering Medications:
- Xanthine Oxidase Inhibitors (XOIs):
- Allopurinol: This is the most commonly prescribed ULT. It works by blocking the enzyme xanthine oxidase‚ which is involved in uric acid production. Starting doses are typically low and gradually increased until the target uric acid level is reached.
- Febuxostat: Similar to allopurinol‚ febuxostat also inhibits xanthine oxidase‚ reducing uric acid production. It may be an option for individuals who cannot tolerate allopurinol or who do not achieve their target uric acid levels with allopurinol.
- Uricosurics:
- Probenecid: This medication helps the kidneys excrete more uric acid‚ thereby lowering the levels in the blood; It is typically used in patients who underexcrete uric acid and have normal kidney function.
- Lesinurad: This drug inhibits transporters in the kidney responsible for uric acid reabsorption‚ increasing its excretion. It is often used in combination with an XOI.
- Pegloticase: This is an enzyme that converts uric acid into a harmless substance that can be easily excreted. It is typically reserved for severe‚ chronic gout that has not responded to other treatments. It is administered intravenously.
Important Considerations
Patients who have never used uric acid-lowering medication should generally not start it during an acute gout flare. It’s common for ULTs to be initiated a few weeks after a flare has resolved. Additionally‚ during the initial phase of ULT‚ there can be a temporary increase in gout flares as existing crystals begin to dissolve. To mitigate this‚ healthcare providers often prescribe prophylactic anti-inflammatory medication (like low-dose colchicine or NSAIDs) for several months after starting ULT.
Close monitoring of uric acid levels is essential to ensure treatment efficacy. Lifestyle modifications‚ including diet and hydration‚ also play a significant role in managing gout alongside medication.
